Koch W - Search Results

1

Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.

Koch W, Böttiger C, Mehilli J, von Beckerath N, Neumann FJ, Schömig A, Kastrati A. Koch W, et al. Am J Cardiol. 2001 Nov 15;88(10):1120-4. doi: 10.1016/s0002-9149(01)02045-8. Am J Cardiol. 2001. PMID: 11703955

2

CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction.

Koch W, Kastrati A, Mehilli J, von Beckerath N, Schömig A. Koch W, et al. Am Heart J. 2002 Jun;143(6):971-6. doi: 10.1067/mhj.2002.122512. Am Heart J. 2002. PMID: 12075251

3

G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease.

von Beckerath N, Schusterschitz Y, Koch W, Griesser K, Mehilli J, Gorchakova O, Schömig A, Kastrati A. von Beckerath N, et al. Among authors: koch w. Atherosclerosis. 2003 Mar;167(1):135-9. doi: 10.1016/s0021-9150(02)00422-7. Atherosclerosis. 2003. PMID: 12618278

4

Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement.

Gorchakova O, Koch W, von Beckerath N, Mehilli J, Schömig A, Kastrati A. Gorchakova O, et al. Among authors: koch w. Eur Heart J. 2003 May;24(9):820-7. doi: 10.1016/s0195-668x(02)00824-2. Eur Heart J. 2003. PMID: 12727149

5

Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.

Koch W, Mehilli J, von Beckerath N, Böttiger C, Schömig A, Kastrati A. Koch W, et al. J Am Coll Cardiol. 2003 Jun 4;41(11):1957-61. doi: 10.1016/s0735-1097(03)00406-6. J Am Coll Cardiol. 2003. PMID: 12798565 Free article.

6

Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.

Koch W, Tiroch K, von Beckerath N, Schömig A, Kastrati A. Koch W, et al. Cytokine. 2003 Nov 21;24(4):161-71. doi: 10.1016/j.cyto.2003.08.004. Cytokine. 2003. PMID: 14572794

7

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.

Böttiger C, Koch W, Lahn C, Mehilli J, von Beckerath N, Schömig A, Kastrati A. Böttiger C, et al. Among authors: koch w. Am Heart J. 2003 Nov;146(5):855-61. doi: 10.1016/S0002-8703(03)00363-6. Am Heart J. 2003. PMID: 14597935

8

Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.

Koch W, Ndrepepa G, Mehilli J, Braun S, Burghartz M, Lengnick H, Kölling K, Schömig A, Kastrati A. Koch W, et al. Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2229-34. doi: 10.1161/01.ATV.0000105055.68038.29. Epub 2003 Nov 6. Arterioscler Thromb Vasc Biol. 2003. PMID: 14604831

9

The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.

Hoppmann P, Koch W, Schömig A, Kastrati A. Hoppmann P, et al. Among authors: koch w. Eur Heart J. 2004 Feb;25(4):335-41. doi: 10.1016/j.ehj.2003.12.004. Eur Heart J. 2004. PMID: 14984923

10

Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.

Kölling K, Ndrepepa G, Koch W, Braun S, Mehilli J, Schömig A, Kastrati A. Kölling K, et al. Among authors: koch w. Am J Cardiol. 2004 May 15;93(10):1201-6. doi: 10.1016/j.amjcard.2004.02.009. Am J Cardiol. 2004. PMID: 15135689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,610 results

Search Page

Filters